Low or no NR2F1 protein in cells that metastasize from primary breast tumors to bone marrow indicates a high risk of lethal cancer recurrence, says study.
Low or no NR2F1 protein in cells that metastasize from primary breast tumors to bone marrow indicates a high risk of lethal cancer recurrence, says study.
